Protara Therapeutics, Inc.
TARA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,258 | -$14,960 | -$11,914 | -$12,769 |
| Dep. & Amort. | $88 | $98 | $83 | $82 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $833 | $904 |
| Change in WC | -$206 | $1,808 | -$3,812 | $2,495 |
| Other Non-Cash | $924 | $804 | $97 | -$20 |
| Operating Cash Flow | -$12,452 | -$12,250 | -$14,713 | -$9,308 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$22 | -$44 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$24,412 | -$51,701 | -$65,810 | $0 |
| Inv. Sales/Matur. | $17,910 | $4,000 | $7,500 | $22,500 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$6,506 | -$47,723 | -$58,354 | $22,500 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $13 | $8 | $1,915 | $94,042 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$185 | $3,807 |
| Financing Cash Flow | $13 | $8 | $1,730 | $97,849 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$18,945 | -$59,965 | -$71,337 | $111,041 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $31,496 | $91,461 | $162,798 | $52,502 |
| End Cash | $12,551 | $31,496 | $91,461 | $163,543 |
| Free Cash Flow | -$12,456 | -$12,272 | -$14,757 | -$9,308 |